04/02/2023
12:17:46
+44 (0) 203 8794 460
Free Membership
Login
Watchlist
Kurse
Charts
Trades
News
Fundamental
Toplisten
Alerts
Portfolio
Orderbuch
Forum
PLUS1
₿
Krypto
Börse & Märkte
Devisen
Welt Märkte
Follow Feed
Treten Sie unserer Gemeinschaft von Investoren!
JETZT ANMELDEN
Startseite
Investieren
Aktien
USA
NYSE
Merck and Co Inc
(MRK)
Finanzwerte
Börsenkurse
Charts
Orderbuch
Trades
News
Finanzwerte
Historisch
Merck & Company Inc. (MRK) Fundamentals
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
SHARE INFORMATION
Market Cap
US$ 262.312.067.470
Shares Outstanding
2.535.395.974
Float
2.533.910.185
Percent Float
99,94%
Short Interest
0,00
Short Percent Float
0,0%
Short Interest Ratio
0,00
Short Interest Date
-
Latest Fiscal Dividend Per Share
US$ 2,64
Latest Fiscal Revenue
US$ 50.157.000.000
Latest Fiscal EPS
US$ 5,14
Latest Fiscal Date
2021-12-31
DIVIDENDS
Dividend (3 Years)
US$ 6,66
Dividend (5 Years)
US$ 8,18
Ex Dividend Date
2023-03-14
Dividend Rate
US$ 2,92
Dividend Yield
2,82%
Payment Cash
Cash
HOLDERS
Institutions
4.764
Institutional Holdings Date
2023-01-31
Institutional Bought Previous 3 Months
100.271.411
Institutional Holdings Percent
131,5%
Institutional Sold Previous 3 Months
150.416.786
Insider Holdings Date
2022-12-31
Insider Bought Previous 3 Months
2.892.957
Insider Holdings Percent
0,1
Insider Sold Previous 3 Months
5.811.251
Insider Shares Owned
3.606.485
TRADING INFO
52 Week High
US$ 115,49
52 Week Low
US$ 72,88
52 Week High Change
US$ 30,21
21 Day Moving Average
US$ 109,481
21 Day Extended Moving Average
US$ 108,3364
50 Day Moving Average
US$ 109,402
50 Day Extended Moving Average
US$ 107,4381
200 Day Moving Average
US$ 94,5818
200 Day Extended Moving Average
US$ 97,1561
10 Day Average Volume
8.993.480
20 Day Average Volume
9.110.012
30 Day Average Volume
8.224.614
50 Day Average Volume
9.052.717
Alpha
0.011649
Beta
0.3560
Standard Deviation
0.060153
R2
0.102177
7 Day Price Change
US$ -3,41
7 Day Percent Change
-3,19%
21 Day Price Change
US$ -8,31
21 Day Percent Change
-7,43%
30 Day Price Change
US$ -7,49
30 Day Percent Change
-6,75%
Month to Date Price Change
US$ -3,95
Month to Date Percent Change
-3,68%
Quarter to Date Price Change
US$ -7,49
Quarter to Date Percent Change
-6,75%
180 Day Price Change
US$ 17,12
180 Day Percent Change
19,83%
200 Day Price Change
US$ 9,88
200 Day Percent Change
10,56%
Year to Date Price Change
US$ -7,49
Year to Date Percent Change
-6,75%
Merck & Company Inc. (MRK) Key Ratios
PROFITABILITY
EBIT Margin
30,1%
EBITDA Margin
36,7%
Pre-Tax Profit Margin
16,2%
Profit Margin Count
25,32%
Gross Margin
70,5%
Profit Margin TOT
25,32%
INCOME STATEMENTS
Revenue
US$ 45.453.000.000
Revenue Per Share
US$ 17,9274
Revenue (3 Years)
US$ 0,10
Revenue (5 Years)
US$ 3,71
FINANCIAL STRENGTH
Price to Tangible Book
140,50
Total Debt To Equity
0,70
Int Coverage
19,00
Current Ratio
1,50
Leverage Ratio
2,50
Quick Ratio
0,90
Long Term Debt To Capital
0,39
VALUATION MEASURES
PE Ratio
17,80
Enterprise Value
US$ 290.406.661.298
Price to Sales
5,7711
Price to Free Cash
44,90
PE High Last 5 Years
87,90
Price To Book
6,10
Price To Cash Flow
13,80
PE Low Last 5 Years
16,30
Price to Tangible Book
140,50
MANAGEMENT EFFECTIVENESS
Receivables Turnover
2,10
Invoice Turnover
3,00
Assets Turnover
0,20
Return Assets
15,22
Return on Equity
38,03
Return on Capital
23,41
Merck & Company Inc. (MRK) Profile
PROFILE INFO
Issue Type
CS
SEC Type
EQS
Auditor
PricewaterhouseCoopers LLP
CEO
Robert M. Davis
Emplyoees
68000
Last Audit
UQ
CIK
0000310158
Industry
Drug Manufacturers
Sector
Healthcare
NAICS
Pharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address
2000 Galloping Hill Road
Kenilworth, NJ 7033
Website
https://www.merck.com
Facsimile
-
Telephone
+1 908 740-4000
Email
investor_relations@merck.com
Kürzlich von Ihnen besucht
NYSE
MRK
Merck
Register now
to watch these stocks streaming on the ADVFN Monitor.
Monitor lets you view up to 110 of your favourite stocks at once and is
completely free
to use.
Melden Sie sich bei ADVFN an
Jetzt registrieren
Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende
Allgemeine Geschäftsbedingungen
Investitionen Warnung
Copyright © 1999 - 2023
Datenschutzrichtlinie
Zustimmungseinstellungen
ADVFN UK
Investors Hub
ADVFN Italy
ADVFN Australia
ADVFN Brazil
ADVFN Canada
ADVFN Germany
ADVFN Japan
ADVFN Mexico
ADVFN France
ADVFN US
P: V:de D:20230204 12:17:46